Ginger Extract for Asthma

(GINGER Trial)

ED
CE
Overseen ByCharles Emala, MD
Age: 18+
Sex: Any
Trial Phase: Phase 2
Sponsor: Emily DiMango, MD
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)
Prior Safety DataThis treatment has passed at least one previous human trial

What You Need to Know Before You Apply

What is the purpose of this trial?

Primary Objective: The primary endpoint is a clinically significant improvement in tolerance to inhaled methacholine (PD20).

Secondary Objectives: 1) To determine if oral daily ginger extract intake - decreases fractional excretion of nitric oxide; decreases blood eosinophilia; decreases asthma-associated cytokines in serum; decreases medium chain fatty acids; improves asthma symptoms; and 2) Establish pharmacokinetic parameters of biologically active components of ginger in adult asthmatics.

Who Is on the Research Team?

ED

Emily DiMango, MD

Principal Investigator

Columbia University

Are You a Good Fit for This Trial?

This trial is for adults with asthma. People who have other major health issues or conditions that could interfere with the study may not be able to participate.

Inclusion Criteria

Smoking history of ≤10 pack-years
Non-smoker of tobacco, e-cigarettes, or marijuana for ≥1 year; nicotine patch or gum permitted
Suboptimal asthma control as determined by an Asthma Control Test (ACT) score ≤19 at Screening and Randomization Visits
See 5 more

Exclusion Criteria

Use of investigational treatment within previous 30 days
I have taken oral steroids in the past 6 weeks.
Current drug or alcohol use or dependence interfering with adherence to study requirements
See 8 more

What Are the Treatments Tested in This Trial?

Interventions

  • Ginger Extract

Trial Overview

The study compares daily oral ginger extract to a placebo in adults with asthma. Researchers want to see if ginger helps improve breathing and reduces inflammation, using a randomized design where participants are assigned by chance.

How Is the Trial Designed?

4

Treatment groups

Experimental Treatment

Group I: Placebo - Active Drug (3gm)Experimental Treatment2 Interventions
Group II: Placebo - Active Drug (2gm)Experimental Treatment2 Interventions
Group III: Active drug - Placebo (3gm)Experimental Treatment2 Interventions
Group IV: Active drug - Placebo (2gm)Experimental Treatment2 Interventions

Find a Clinic Near You

Who Is Running the Clinical Trial?

Emily DiMango, MD

Lead Sponsor

Trials
1
Recruited
50+

National Center for Complementary and Integrative Health (NCCIH)

Collaborator

Trials
886
Recruited
677,000+